Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Fragmin found to reduce heart attack and death at 45 days

March 10, 1999

Subanalyses of abciximab trial results presented at ACC meeting

March 10, 1999

Yamanouchi describes novel anticoagulants

March 10, 1999

Hyseq conducts preclinical testing on novel anticoagulant products

March 10, 1999

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

March 9, 1999

Novel hemostatic cofactors available for licensing from OMRF

March 9, 1999

Microbial fatty acid enhances endothelial cell fibrinolytic activity

March 8, 1999

Bio-Technology General receives added patent protection for novel anticoagulant

March 8, 1999

Pharmacia & Upjohn and Centocor to copromote Fragmin in unstable angina

March 8, 1999

Antithrombotic P2T antagonists in development at Astra

March 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...